Trial Profile
Rosiglitazone Add-On in Treatment of Depressed Patients With Insulin Resistance: a Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Insulin resistance
- Focus Pharmacodynamics
- 05 Jun 2012 Actual patient number 10 added as reported by ClinicalTrials.gov.
- 05 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jun 2012 Actual end date (1 Dec 2009) added as reported by ClinicalTrials.gov.